Tag: 2016

  • Lord Beecham – 2016 Parliamentary Question to the Department for Communities and Local Government

    Lord Beecham – 2016 Parliamentary Question to the Department for Communities and Local Government

    The below Parliamentary question was asked by Lord Beecham on 2016-02-22.

    To ask Her Majesty’s Government what progress they have made on devolution deals for non-metropolitan areas.

    Baroness Williams of Trafford

    The Government is determined to rebalance the economy and empower local government through the devolution of powers away from Whitehall. We have already agreed seven ground-breaking devolution deals with areas ranging from Liverpool to Cornwall.

    The Government is progressing devolution discussions with non-metropolitan areas that submitted devolution proposals in September 2015. We are at an advanced stage in negotiations with a number of non-metropolitan areas and expect to be able to announce further deals in the near future.

  • Paula Sherriff – 2016 Parliamentary Question to the Department for Transport

    Paula Sherriff – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Paula Sherriff on 2016-03-10.

    To ask the Secretary of State for Transport, what commercial sensitivity applies to section 106 (staff using handheld tablets) and section 28.1 (movement of staff) of the agreement between NXET Trains Limited and his Department of 15 July 2014 regarding the Essex Thameside franchise.

    Claire Perry

    The provisions mentioned have been redacted at the request of either the Director General for Rail or the Secretary of State in accordance with the provisions of the Freedom of Information Act 2000.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-04-14.

    To ask Her Majesty’s Government what impact assessment they made of the introduction of CQUIN scheme BI1 Improving HCV Treatment Pathways through ODNs, and whether they will publish a copy of that assessment.

    Lord Prior of Brampton

    The National Institute for Health and Care Excellence specifically requires Operational Delivery Networks to prioritise hepatitis C patients on the basis of clinical need, as part of a progressive rollout of treatments over the next five years and the Commissioning for Quality and Innovation scheme (CQUIN) enables and ensures this take place. There is no separate assessment of impact. NHS England recognises that there is a very significant improvement in inequalities as a result of roll-out treatment for hepatitis C.

  • Lilian Greenwood – 2016 Parliamentary Question to the Department for Transport

    Lilian Greenwood – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Lilian Greenwood on 2016-05-24.

    To ask the Secretary of State for Transport, pursuant to the Answer of 23 May 2016 to Question 37536, on Govia Thameslink Railway Reforms Standards, what the predefined contractual change referred to in that Answer is; and what changes have been made to the cancellation and train operating company Minute Delay benchmarks.

    Claire Perry

    When competing for the Thameslink Southern and Great Northern (TSGN) franchise the Department for Transport gave all bidders certain assumptions to use in relation to the train services to be provided until December 2015 and informed them where it would be a Change to the Franchise Agreement if the actual position was different. As a result of the Change, the benchmarks were reviewed.

  • Andrew Rosindell – 2016 Parliamentary Question to the Ministry of Defence

    Andrew Rosindell – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Andrew Rosindell on 2016-07-11.

    To ask the Secretary of State for Defence, what steps his Department is taking to ensure that the rollout of the new submarines for the replacement Trident programme does not disrupt the Government’s commitment to having a constant at-sea deterrent.

    Harriett Baldwin

    As set out in the 2015 Strategic Defence and Security Review, we are taking steps to manage the defence nuclear enterprise and ensure the Successor submarines are delivered to time and budget. As part of this, we have established a new Director-General Nuclear to act as single and accountable focal point within the Ministry of Defence for all aspects of the defence nuclear enterprise. We are also establishing a new submarine delivery body for the procurement and in-service support of all nuclear submarines, including the Successor submarines. We have deliberately moved away from a traditional single ‘Main Gate’ approach, to a staged investment approach with multiple control points. This will enable us to better regulate and control programme funding and delivery.

    The rollout of the Successor submarines supports the programme to maintain a Continuous at Sea Deterrent.

  • Ian Austin – 2016 Parliamentary Question to the Department of Health

    Ian Austin – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ian Austin on 2016-10-07.

    To ask the Secretary of State for Health, when and by whom the decision was taken to give heroin to heroin addicts in line with his Department’s policy set out on page 31 of Modern Crime Prevention Strategy, published by his predecessor in March 2016.

    Nicola Blackwood

    The prescribing of injectable opioids, such as methadone or diamorphine (pharmaceutical heroin) as substitutes for illicit heroin, as outlined in the Government’s Modern Crime Prevention Strategy, published in March by the then Home Secretary, has been an option for many years but since the late 1960s, prescribing of diamorphine for the management of addiction has been restricted to licensed addiction specialists.

    The decision to prescribe injectable diamorphine for the treatment of dependence is a clinical matter, for a clinician to take in conjunction with the patient. Advice to guide these decisions is contained in Chapter 5 and Annex 8 of the 2007 UK Guidelines on the Clinical Management of Drug Misuse and Dependence. The guidelines advise that:

    – “injectable opioid treatment may be suitable for a small minority of patients who have failed in optimised oral treatment.”;

    – “clinicians providing injectable opioid treatment should encourage patients not to regard it as a lifelong treatment option and should regularly review their patients and the continuing necessity for this unusual and expensive treatment”; and

    – The use of diamorphine “alone does not constitute drug treatment…it should be seen as on element or pathway within wider packages of planned and integrated drug treatment”.

    The guidelines are currently being reviewed by an Expert Working Group, to take into account developments in the evidence base. In July 2016, the Expert Working Group published their draft update for consultation. The consultation has closed and the responses are being considered by the Expert Working Group.

    Diamorphine is licensed as a medicine by the Medicines and Healthcare products Regulatory Agency. Clinicians wishing to legally prescribe it for the treatment of dependence need to obtain a licence for that purpose from the Home Office and to comply with all other legislation relevant to the safe management, use and supply of medicines which are controlled drugs.

  • Gregory Campbell – 2016 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    Gregory Campbell – 2016 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    The below Parliamentary question was asked by Gregory Campbell on 2016-01-25.

    To ask the Secretary of State for Environment, Food and Rural Affairs, by how much levels of pollution have changed in the UK territorial seas in the last five years.

    George Eustice

    Inputs into the marine environment of the six most hazardous polluting substances (cadmium, lindane, mercury, zinc, copper and lead) have fallen significantly over the last 25 years. In the five years to 2013 inputs of five of the substances have declined while mercury inputs were stable. These trends are reported in the UK’s Biodiversity Indicators, published this month.

    The volume of oil accidentally spilled varies widely from year to year, is generally small and of relatively minor significance, with no major spills in UK waters having occurred over the last five years.

    Assessments of contaminants in the recent UK Marine Strategy Part 3, published in December, have shown that most problems (i.e. where concentrations or biological effects parameters exceed assessment thresholds) are local in nature and close to the sources, particularly in industrialised estuaries and coasts, and largely caused by historic pollution.

  • Baroness Hodgson of Abinger – 2016 Parliamentary Question to the Department of Health

    Baroness Hodgson of Abinger – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Baroness Hodgson of Abinger on 2016-02-22.

    To ask Her Majesty’s Government how many (1) children under 9 years of age, (2) children aged between 9 and 16 inclusive, and (3) adults over 18, have been diagnosed with autism in each of the last five years.

    Lord Prior of Brampton

    The number of children, young people and adults diagnosed with autism by the National Health Service is not collected centrally. Latest figures from the School Census (2015) state that there were 90,775 pupils with an autistic spectrum disorder at state funded schools and non-maintained special schools in England. This has increased from a total of 56,250 in 2010 who were recorded as having a primary need of autism, but it is not directly comparable to the 2015 figures because of a change in collection methodology. Local authority areas provide information for Public Health England’s annual self-assessment exercise on implementing the Autism Strategy. This includes the number of adults receiving an autism diagnosis but because information is submitted on a voluntary basis a complete total for England is not available.

    The Department has discussed with NHS England the difficulties that people on the autistic spectrum can have in getting an appropriate diagnosis and support in a timely manner. NHS England has commenced a programme to visit clinical commissioning groups to identify and share good practice in accessing autism diagnosis, and look at possible barriers. The Department is funding the Association of Directors of Adult Social Services to support this work. NHS England will complete a report on this by the end of April 2016.

    The Department is also encouraging the autism third sector to work together and the four charity representatives on the Cross Government Autism Programme Board, which oversees the implementation of the Autism Strategy, gave presentations at the meeting on 18 February on work they are doing to increase public awareness. The charities are the National Autistic Society, the Autism Alliance UK, Autism Plus and Ambitious about Autism. The Autism Alliance UK is also being funded by the Department to undertake work with national and local organisations, to make reasonable adjustments to services and to train staff to be aware of what autism can mean to individuals who have the condition and their families.

    The Health and Social Care Information Centre’s publication Estimating the Prevalence of Autism Spectrum Conditions in Adults – Extending the 2007 Adult Psychiatric Morbidity Survey (APMS) gave the overall prevalence of autism in England as 1.1% (95% confidence interval 0.3% to 1.9%). Among adults with learning disabilities living in private households whose learning disability was sufficiently severe that they could not have taken part in the 2007 APMS, the prevalence of autism was 35.4% (95% confidence interval 24.7% to 46.2%). Among adults with mild or severe learning disabilities living in communal care establishments, the prevalence of autism was 31% (95% confidence interval 23.9% to 38%). Detailed supporting information regarding the underlying data and how figures have been derived is found within the detail of the report, a copy of which is attached.

    The APMS was repeated in 2014 and findings are scheduled to be published in September 2016.

  • Tulip Siddiq – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Tulip Siddiq – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Tulip Siddiq on 2016-03-10.

    To ask the Secretary of State for Business, Innovation and Skills, if he will estimate the proportion of (a) mothers and (b) fathers in the labour force who were not able to claim statutory parental leave because of the requirement for 26 weeks of continuous employment with the same employer in the last 12 months.

    Nick Boles

    The Shared Parental Leave and Pay system is designed to strike the right balance between giving employees flexibility and giving their employers the certainty that they need to plan.

    We do not routinely collect information that would enable us to estimate the proportion of (a) mothers and (b) fathers in the labour force who were not able to claim Shared Parental Leave and Pay because of the ‘continuity of employment requirement’.

  • Tulip Siddiq – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Tulip Siddiq – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Tulip Siddiq on 2016-04-14.

    To ask the Secretary of State for Business, Innovation and Skills, how many (a) mortgages, (b) leaseholds and (c) properties overall are registered with the Land Registry in (i) Hampstead and Kilburn constituency and (ii) London.

    Anna Soubry

    The information will take time to collate. I will place this in the Libraries of the House as soon as the information is available.